http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008044144-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47c4cefdfd4058d5e9e5c235ccb149bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71bedddeec02bc740429fc8dc6eacc63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af6d9a6a5a0749d7f412d82276b971c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_785b1a9ccba4d22d7a430ce4dae50c58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf3edbcc4eff0637b26151ddf7aeb4a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
filingDate 2007-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62a5a0c9c405cfd6112f25afa95aa957
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_674bb57bc0920545b1774f0c64deadf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d44bae8618665aa38e91dc6e6bcd47a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b7880da2ed2b05b58449682625ae5c
publicationDate 2008-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008044144-A3
titleOfInvention Chiral tetra-hydro beta-carbolic derivatives and applications thereof as antiparasitic compounds
abstract The invention relates to the use of chiral tetra-hydro β-carboline derivatives of formula (I) for the preparation of pharmaceutical composition for the prevention and/or the treatment of parasitic diseases involving parasites having a phosphodiesterase activity: or a pharmaceutically acceptable salt thereof, in which: - R1 and R2, identical or different, represent a hydrogen atom or a fluorine atom; - k is an integer equal to 0 or 1; - R3 is selected from the group consisting of: a phenyl ring optionally substituted a 3'-N-pyridine ring optionally substituted - R4 is a group selected in the group consisting of the following groups: -NH-A-R5, -NHC(O)-R5 and the groups of formulas (ll-a) to (ll-c) below: The invention also relates to some new chiral tetra-hydro β-carboline derivatives.
priorityDate 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03042213-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0168648-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67486

Total number of triples: 28.